Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

TD Cowen Downgrades PhenomeX to Market Perform, Announces $1 Price Target

Author: Benzinga Newsdesk | August 23, 2023 03:26am
TD Cowen analyst Steven Mah downgrades PhenomeX (NASDAQ:CELL) from Outperform to Market Perform and announces $1 price target.

Posted In: CELL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist